![Lars Thomander](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lars Thomander
Corporate Officer/Principal bei University of Uppsala
Aktive Positionen von Lars Thomander
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Uppsala | Corporate Officer/Principal | - | - |
Karriereverlauf von Lars Thomander
Ehemalige bekannte Positionen von Lars Thomander
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Abbott Scandinavia AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 | 01.01.2013 |
AbbVie AB
![]() AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 | 01.01.2013 |
ELI LILLY AND COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Foundation for Pharmaceutical Medicine | Direktor/Vorstandsmitglied | - | - |
Swedish Pharmaceutical Society | Präsident | - | - |
Hlt Konsult AB | Direktor/Vorstandsmitglied | - | - |
Gründer | - | - | |
CaptiGel AB
![]() CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Vorsitzender | 01.01.2014 | - |
Double Bond Pharmaceutical International AB
![]() Double Bond Pharmaceutical International AB BiotechnologyHealth Technology Double Bond Pharmaceutical International AB is a pharmaceutical company, which engages in developing and commercializing approaches for treatment of cancers, infections, autoimmune diseases, and life-threatening disorders. It also involves in designing medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes. The company was founded on November 21, 2014 and is headquartered in Uppsala, Sweden. | Direktor/Vorstandsmitglied | 01.04.2015 | - |
Statistik
International
Schweden | 9 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Chairman | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
![]() | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Private Unternehmen | 6 |
---|---|
CaptiGel AB
![]() CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Health Technology |
Hlt Konsult AB | |
Abbott Scandinavia AB | |
AbbVie AB
![]() AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Commercial Services |
Swedish Pharmaceutical Society | |
Foundation for Pharmaceutical Medicine |
- Börse
- Insiders
- Lars Thomander
- Erfahrung